Knowledge%20Translation%20(and%20Exchange)%20for%20Vaccine-Preventable%20Diseases%20(VPDs)

1
Knowledge Translation (and Exchange) for
Vaccine-Preventable Diseases (VPDs)

• CPHA Conference
• May 27th, 2014
• Lisa Paddle, Nurse Advisor

2
Presentation Outline

• What is Knowledge Translation and Exchange (KTE)
  and why is it important?
• KTE in context of Vaccine-Preventable Disease
  Surveillance
• The right audience
• The right time
• The right tools
• Additional Learning Resources/KTE Mechanisms

3
What is knowledge translation (KT) / exchange
(KTE)?

• a dynamic and iterative process that includes
  synthesis, dissemination, exchange and
  ethically-sound application of knowledge to
  improve the health of Canadians, provide more
  effective health services and products and
  strengthen the health care system (Source
  Canadian Institutes of Health Research)
• This process takes place within a complex system
  of interactions between researchers and knowledge
  users that vary in intensity, complexity and
  level of engagement depending on the nature of
  the research and the findings as well as the
  needs of the particular knowledge user

4
Knowledge Translation Models

• Based on 31 planned action theories
• Designed to be used by broad range of audiences
• Key is importance of appropriate relationships
• Fluid, non-linear

5
Knowledge translation is about the application
and use of the best available science to benefit
health and well-being.
Knowledge output
Knowledge uptake/ impact
The right information to the right people in the
right way at the right time
6
VPD Surveillance How to translate science to
knowledge
7
Who were our key surveillance stakeholders?

• Government
• PHAC (other Centres Divisions)
• National Microbiology Laboratory (NML)
• Health Canada (First Nations, Vaccine Regulation)
• Provincial / Territorial (P/T) VPD / immunization
  programs

• International organizations
• Centres for Disease Control Prevention (CDC)
• Pan-American Health Organization (PAHO)
• World Health Organization (WHO)

• Professional organizations
• Canadian Paediatric Society (CPS)
• Immunize Canada
• Society for Obstetricians Gynaecologists (SOGC)
• Canadian Public Health Association (CPHA)
• Etc.

• F-P-T / Expert Committees
• Canadian Immunization Committee (CIC)
• National Advisory Committee on Immunization
  (NACI)
• Committee to Advise on Tropical Medicine and
  Travel (CATMAT)

Immunization and Respiratory Infectious Diseases

• Immunization providers
• Local public health units
• Primary health providers
• Hospitals
• Long-Term Care Homes
• Occupational health services

• Research community
• Canadian Association of Immunization research and
  Evaluation (CAIRE)
• PHAC-CIHR Influenza Research Network (PCIRN)
• Vaccine evaluation centres
• IMPACT
• Individual researchers students

• General public
• Individuals / parents
• Media
• Public advocacy groups

8
What was our key mechanism?
9

• Objectives of Vaccine-Preventable Disease
  Surveillance
• To provide timely, quality national surveillance
  data to detect trends in disease incidence
• To provide information to support program
  planning and evaluation, outbreak response and
  future policy and program decision-making
• To increase knowledge and understanding of the
  epidemiology of vaccine preventable diseases
  through innovative enhanced surveillance systems
  and research

10
Goal of Knowledge Translation in the Context of
VPD Surveillance

• To align national VPD surveillance products with
  the information needs of key partners
  stakeholders and effectively (and efficiently)
  inform immunization and vaccine-preventable
  disease program decisions.
• VPDs include
• Invasive meningococcal disease (IMD) Varicella
• Invasive pneumococcal disease (IPD) Polio
• Pertussis Diphtheria
• Measles Tetanus
• Mumps Haemophilus influenza disease
• Rubella GBS/iGAS

11
KTE Strategy for Vaccine-Preventable Disease
Surveillance
KTE on Vaccine-Preventable Diseases

• Notifiable Diseases On-line for aggregate case
  counts at the national level
• Routine cycle for publication of surveillance
  reports up to 2023 (Canada Communicable Disease
  Reports)
• Q1 (Polio/AFP measles rubella CRS)
• Q2 years (IMD)
• Q 5 years (Invasive Bacterial Diseases including
  Hi, IPD, iGBS, iGAS, International Circumpolar
  Surveillance, Pertussis)
• Exploring options around weekly online measles
  reports
• VPD surveillance on Agency Website
• All products (e.g. Canadian Immunization Guide)
  will point here.
• National Advisory Committee on Immunization
  (NACI) Statements
• For product or strain-specific epidemiologic
  analysis
• Peer Review journals for specific level of
  analysis
• Disease Guidelines for epidemiologic summaries

12
Government of Canada Web Renewal Action Plan
(GCWRAP)

• www.Canada.ca by the end of 2016
• One website
• User-centric
• Modernized, leaner
• Accessible (hand-held devices as well as
  assistive technologies)
• Resources

This single site (Canada.ca) approach will
require that the Government of Canada
fundamentally transform its web presence to
better meet the needs of Canadians by being
user-centric.
13
Immunization and Vaccines Landing Page (before)
14
Immunization and Vaccines Landing Page (After)
http//www.phac-aspc.gc.ca/im/index-eng.php
15
New Vaccine-Preventable Diseases Landing Pages

• General Public (plain language) AND Health
  Professional audiences
• De-duplication
• Audience-specific
• Organized and easy to navigate
• Hyperlinks to relevant content
• Images/sounds, as appropriate
• Surveillance section How is surveillance done
  on this VPD in Canada?
• Health Professionals information and resources
  specific to Health Professionals

16
Select KTE Learning Resources
KTE on Vaccine-Preventable Diseases

• PHAC Knowledge Translation Primer
  (http//publications.gc.ca/collections/collection_
  2013/aspc-phac/HP35-37-2012-eng.pdf)
• National Collaborating Centre for Methods and
  Tools (http//www.nccmt.ca/)
• CIHR Population and Public Health Institute
  (http//www.cihr-irsc.gc.ca/e/27155.html)
• KT Clearinghouse www.ktclearinghouse.ca
• Institute for Knowledge Mobilization
  (www.knowledgemobilization,net)
• Health Evidence (www.health-evidence.org)

Some KTE mechanisms for Vaccine-Preventable
diseases Public Health Agency of Canada Website
Immunization and Vaccines Canadian Immunization
Guide Canada Communicable Disease Reports
(CCDR) CNPHI (Canadian Network for Public Health
Intelligence) (Public Health Alerts)
17
Acknowledgements

• Heather Deehan, Chief Vaccine Preventable
  Diseases (PHAC)
• Anita Li, Tiffany Smith, Amanda Shane, Lindsey
  Sherrard, Epidemiologists VPD section (PHAC)
• Dr. Shalini Desai, Medical Specialist (PHAC)
• Nadine Abboud, Project Management Support (PHAC)
• Monique St-Laurent, A/Director Vaccine and
  Immunization Program Surveillance Division (PHAC)
• Dr. John Spika, Director General, Centre for
  Immunization and Respiratory Infectious Diseases
  (CIRID) (PHAC)
• Robert Lerch, Oliver Baclic, Althea House, CIG
  secretariat (PHAC)
• Tara Harris, Public Health Ontario(formerly PHAC)